Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Subscribe To Our Newsletter & Stay Updated
